Content - ETOP BOOSTER

ETOP BOOSTER - osimertinib and bevacizumab versus osimertinib alone for patients with NSCLC

For further information about the trial ETOP BOOSTER please visit the ETOP-Website: www.etop-eu.org

Study Chairs:

PD Dr. med. Martin Früh, Cantonal Hospital St.Gallen, +41 71 494 10 68

Locations for this trial:

Centre Hospitalier Universitaire Vaudois CHUV
Rue du Bugnon 46
0 Lausanne
Kantonsspital St. Gallen
Rorschacher Strasse 95
0 9007 St. Gallen
Kantonsspital Winterthur
Brauerstrasse 15
0 8401 Winterthur
UniversitätsSpital Zürich
Rämistrasse 100
0 8091 Zürich